Cargando…

Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90

Cancer stem cells (CSCs) are a pivotal target for eradicating hepatocellular carcinoma (HCC). We previously reported that distinctive CSCs regulating tumorigenicity (EpCAM(+) CSCs) and metastasis (CD90(+) CSCs) have different epithelial/mesenchymal gene expression signatures. Here, we examined the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Mariko, Yamashita, Taro, Okada, Hikari, Oishi, Naoki, Nio, Kouki, Hayashi, Takehiro, Nomura, Yoshimoto, Hayashi, Tomoyuki, Asahina, Yoshiro, Ohwada, Mika, Sunagozaka, Hajime, Takatori, Hajime, Colombo, Federico, Porretti, Laura, Honda, Masao, Kaneko, Shuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596021/ https://www.ncbi.nlm.nih.gov/pubmed/28900199 http://dx.doi.org/10.1038/s41598-017-11848-z

Ejemplares similares

Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
por: Hayashi, Takehiro, et al.
Publicado: (2017)

De Novo Emergence of Mesenchymal Stem-Like CD105(+) Cancer Cells by Cytotoxic Agents in Human Hepatocellular Carcinoma()()
por: Nomura, Yoshimoto, et al.
Publicado: (2017)

Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study
por: Hayashi, Tomoyuki, et al.
Publicado: (2017)

Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression
por: Asahina, Yoshiro, et al.
Publicado: (2023)

Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma
por: Hashiba, Tomomi, et al.
Publicado: (2020)

Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma
por: Suda, Tsuyoshi, et al.
Publicado: (2022)

FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition
por: Li, Ru, et al.
Publicado: (2022)

Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
por: Suda, Tsuyoshi, et al.
Publicado: (2020)

Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis
por: Suda, Tsuyoshi, et al.
Publicado: (2023)

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
por: Hayashi, Takehiro, et al.
Publicado: (2019)

Identification of a Transmembrane Protein Involved in Shear Stress Signaling and Hepatocarcinogenesis After a Sustained Virological Response to Hepatitis C Virus
por: Nishikawa, Masashi, et al.
Publicado: (2023)

The evolving concept of liver cancer stem cells
por: Nio, Kouki, et al.
Publicado: (2017)

BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma
por: Chen, Han, et al.
Publicado: (2021)

Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors
por: Doan, Phuong Thi Bich, et al.
Publicado: (2023)

Argon plasma coagulation therapy after submucosal injection of normal saline solution for local recurrence of large nonampullary duodenal neoplasm
por: Hayashi, Tomoyuki, et al.
Publicado: (2016)

Efficacy of a novel self-expandable metal stent with dumbbell-shaped flare ends for distal biliary obstruction due to unresectable pancreatic cancer
por: Miyazawa, Masaki, et al.
Publicado: (2022)

Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease
por: Yamada, Kazutoshi, et al.
Publicado: (2018)

The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
por: Shirasaki, Takayoshi, et al.
Publicado: (2018)

BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma
por: Chen, Han, et al.
Publicado: (2022)

Necessity of pharyngeal anesthesia during transoral gastrointestinal endoscopy: a randomized clinical trial
por: Hayashi, Tomoyuki, et al.
Publicado: (2023)

Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study
por: Nakano, Masahito, et al.
Publicado: (2015)

Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients
por: Yamashita, Taro, et al.
Publicado: (2022)

Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells
por: Sakai, Yoshio, et al.
Publicado: (2019)

Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma
por: Terashima, Takeshi, et al.
Publicado: (2016)

Eradication of angiomas by nylon loop snare ligation under total enteroscopy, in disseminated intravascular coagulation associated with blue rubber bleb nevus syndrome
por: Nakagawa, Hidetoshi, et al.
Publicado: (2022)

Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8(+) T cells
por: Mizukoshi, Eishiro, et al.
Publicado: (2022)

Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B
por: Wang, Xuyang, et al.
Publicado: (2017)

Clinical Features and Resistance to Entecavir Monotherapy of Patients with Hepatitis B
por: Takayama, Hideo, et al.
Publicado: (2021)

Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C
por: Ezzikouri, Sayeh, et al.
Publicado: (2015)

Management of biliary stricture in patients with IgG4-related sclerosing cholangitis
por: Miyazawa, Masaki, et al.
Publicado: (2020)

A single hepatitis B virus genome with a reporter allows the entire viral life cycle to be monitored in primary human hepatocytes
por: Sumiyadorj, Ariunaa, et al.
Publicado: (2022)

Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal/stem (regenerative) cell
por: Sakai, Yoshio, et al.
Publicado: (2017)

Establishment and Characterization of a New Cell Line Permissive for Hepatitis C Virus Infection
por: Omura, Hitoshi, et al.
Publicado: (2019)

Upregulation of the Long Noncoding RNA HULC by Hepatitis C Virus and Its Regulation of Viral Replication
por: Kitabayashi, Juria, et al.
Publicado: (2020)

Endoscopic Ultrasonography-Guided Fine Needle Aspiration for Extrahepatic Cholangiocarcinoma: A Safe Tissue Sampling Modality
por: Onoyama, Takumi, et al.
Publicado: (2019)

Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma
por: Kaji, Kiichiro, et al.
Publicado: (2017)

Peroral cholangioscopy‐guided forceps biopsy versus fluoroscopy‐guided forceps biopsy for extrahepatic biliary lesions
por: Onoyama, Takumi, et al.
Publicado: (2020)

Peroral Cholangioscopy-Guided Forceps Biopsy and Endoscopic Scraper for the Diagnosis of Indeterminate Extrahepatic Biliary Stricture
por: Kato, Masayuki, et al.
Publicado: (2019)

Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus
por: Miyazawa, Masaki, et al.
Publicado: (2017)

Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease
por: Kawaguchi, Kazunori, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d8mdniok82d19opipfntp333ir